Birznieks Gunther (CIK 0001702031)

Latest company ownership

VNDA - Vanda Pharmaceuticals Inc.

Role: SVP, Business Development

Shares held

411,628

Last filed at

Mar 4, 2025

Confidence Score

49.9

2025Q4

Confidence Score History

2018Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Mar 1, 2025	Mar 4, 2025	Vanda Pharmaceuticals Inc.	SVP, Business Development	Sell	42.5	-26,941	-6.14%	✗	$128.2K
Mar 4, 2024	Mar 6, 2024	Vanda Pharmaceuticals Inc.	SVP, Business Development	Sell	22.5	-17,411	-5.26%	✗	$73.4K
Mar 2, 2023	Mar 6, 2023	Vanda Pharmaceuticals Inc.	SVP, Business Development	Sell	22.5	-16,777	-7.53%	✗	$104.6K
Feb 28, 2022	Mar 2, 2022	Vanda Pharmaceuticals Inc.	SVP, Business Development	Sell	90.0	+17,099	9.96%	✗	$175.5K
Mar 1, 2021	Mar 3, 2021	Vanda Pharmaceuticals Inc.	SVP, Business Development	Sell	20.0	-20,465	-10.65%	✗	$374K
Mar 2, 2020	Mar 4, 2020	Vanda Pharmaceuticals Inc.	SVP, Business Development	Sell	22.5	-17,758	-10.02%	✗	$181.7K
Jan 2, 2020	Jan 6, 2020	Vanda Pharmaceuticals Inc.	SVP, Business Development	Sell	22.5	-4,020	-2.66%	✗	$64K
Mar 1, 2019	Mar 4, 2019	Vanda Pharmaceuticals Inc.	SVP, Business Development	Sell	20.0	-12,529	-7.65%	✗	$250.1K
Jan 2, 2019	Jan 4, 2019	Vanda Pharmaceuticals Inc.	SVP, Business Development	Sell	22.5	-6,061	-4.33%	✗	$159.8K
Feb 28, 2018	Mar 2, 2018	Vanda Pharmaceuticals Inc.	SVP, Business Development	Sell	95.0	+21,475	18.14%	✗	$159.6K
Jan 2, 2018	Jan 4, 2018	Vanda Pharmaceuticals Inc.	SVP, Business Development	Sell	22.5	-8,568	-6.75%	✗	$130.8K